{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T02:11:24Z","timestamp":1782871884483,"version":"3.54.5"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T00:00:00Z","timestamp":1747872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Individuals with chronic kidney disease (CKD) can experience significant health-related challenges that affect their life participation. Recent studies have identified life participation as a top priority for adults with CKD. This scoping review aims to comprehensively identify studies of interventions that targeted life participation outcomes in adults with predialysis CKD, and identify gaps in the literature.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This scoping review followed the Joanna Briggs Institute (JBI) methodology. Five electronic databases were searched with additional sources identified through backwards chaining. Title and abstract screening were conducted independently by four screeners after initial inter-rater calibration, and full text screening and data extraction were undertaken by two researchers in duplicate. Data analysis was completed using descriptive statistics and narrative synthesis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>This scoping review identified twenty-three studies that examined interventions to support life participation in the CKD population. No studies targeted life participation as a primary outcome. When categorizing studies via the Canadian Model of Occupational Performance and Engagement (CMOP-E) the majority (87%) of interventions targeted personal-physical mechanisms of disability, with a predominant focus on pharmacological (48%) or exercise (35%) interventions. Dedicated outcome measures for life participation were rarely used, with the role-physical, role-emotional and social functioning subscales of the SF-36 quality of life assessment being the most common life participation outcome measures.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This scoping review highlights a lack of research and prioritization of life participation in CKD. It demonstrates the narrow scope of intervention approaches used to support life participation, and limitations in how studies assess life participation. These gaps indicate a need for further research to support this top priority health outcome for the CKD community.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Clinical trial number<\/jats:title>\n            <jats:p>As this is a scoping review, no clinical trial number is provided.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12882-025-04162-8","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T12:15:34Z","timestamp":1747916134000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Exploring interventions to support life participation for adults with chronic kidney disease: a scoping review"],"prefix":"10.1186","volume":"26","author":[{"given":"Mikaela","family":"Correa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roaa","family":"Hussam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Farragher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"key":"4162_CR1","unstructured":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. - Kidney International [Internet]. [cited 2024 Jul 7]. Available from: https:\/\/www.kidney-international.org\/article\/S0085-2538(23)00766-4\/fulltext"},{"key":"4162_CR2","unstructured":"World Health Organization. Global Health Estimates 2020: Disease burden by Cause, Age, Sex, by Country and by Region, 2000\u20132019 [Internet]. Geneva; 2020. Available from: https:\/\/www.who.int\/data\/gho\/data\/themes\/mortality-and-global-health-estimates\/global-health-estimates-leading-causes-of-dalys"},{"issue":"6","key":"4162_CR3","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1093\/gerona\/glr043","volume":"66A","author":"CB Bowling","year":"2011","unstructured":"Bowling CB, Sawyer P, Campbell RC, Ahmed A, Allman RM. Impact of chronic kidney disease on activities of daily living in Community-Dwelling older adults. J Gerontol Ser A. 2011;66A(6):689\u201394.","journal-title":"J Gerontol Ser A"},{"issue":"4","key":"4162_CR4","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1093\/ckj\/sfy134","volume":"12","author":"RN Moorthi","year":"2019","unstructured":"Moorthi RN, Latham-Mintus K. Social isolation in chronic kidney disease and the role of mobility limitation. Clin Kidney J. 2019;12(4):602\u201310.","journal-title":"Clin Kidney J"},{"issue":"3","key":"4162_CR5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1053\/j.ajkd.2013.07.022","volume":"63","author":"CB Bowling","year":"2014","unstructured":"Bowling CB, Muntner P, Sawyer P, Sanders PW, Kutner N, Kennedy R, et al. Community mobility among older adults with reduced kidney function: A study of Life-Space. Am J Kidney Dis. 2014;63(3):429\u201336.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"4162_CR6","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1053\/j.ajkd.2020.03.022","volume":"76","author":"AM Gonz\u00e1lez","year":"2020","unstructured":"Gonz\u00e1lez AM, Gutman T, Lopez-Vargas P, Anumudu S, Arce CM, Craig JC, et al. Patient and caregiver priorities for outcomes in CKD: A multinational nominal group technique study. Am J Kidney Dis. 2020;76(5):679\u201389.","journal-title":"Am J Kidney Dis"},{"key":"4162_CR7","volume-title":"Advancing an occupational therapy vision for health, well-being, and justice through occupation","author":"EA Townsend","year":"2013","unstructured":"Townsend EA, Polatajko HJ, Enabling Occupation II. Advancing an occupational therapy vision for health, well-being, and justice through occupation. 2nd ed. Ottawa, ON: Canadian Association of Occupational Therapists; 2013.","edition":"2"},{"issue":"1","key":"4162_CR8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/1440-1630.12023","volume":"60","author":"C White","year":"2013","unstructured":"White C, Lentin P, Farnworth L. An investigation into the role and meaning of occupation for people living with on-going health conditions. Aust Occup Ther J. 2013;60(1):20\u20139.","journal-title":"Aust Occup Ther J"},{"issue":"3","key":"4162_CR9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/gerona\/glt109","volume":"69A","author":"S Anand","year":"2014","unstructured":"Anand S, Johansen KL, Kurella Tamura M. Aging and chronic kidney disease: the impact on physical function and cognition. J Gerontol Ser A. 2014;69A(3):315\u201322.","journal-title":"J Gerontol Ser A"},{"issue":"9","key":"4162_CR10","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/nrneph.2014.112","volume":"10","author":"XH Wang","year":"2014","unstructured":"Wang XH, Mitch WE. Mechanisms of muscle wasting in chronic kidney disease. Nat Rev Nephrol. 2014;10(9):504\u201316.","journal-title":"Nat Rev Nephrol"},{"key":"4162_CR11","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.archger.2016.10.007","volume":"68","author":"R Chowdhury","year":"2017","unstructured":"Chowdhury R, Peel NM, Krosch M, Hubbard RE. Frailty and chronic kidney disease: A systematic review. Arch Gerontol Geriatr. 2017;68:135\u201342.","journal-title":"Arch Gerontol Geriatr"},{"issue":"1","key":"4162_CR12","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12916-016-0745-9","volume":"14","author":"I Berger","year":"2016","unstructured":"Berger I, Wu S, Masson P, Kelly PJ, Duthie FA, Whiteley W, et al. Cognition in chronic kidney disease: a systematic review and meta-analysis. BMC Med. 2016;14(1):206.","journal-title":"BMC Med"},{"issue":"1","key":"4162_CR13","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/ki.2013.77","volume":"84","author":"S Palmer","year":"2013","unstructured":"Palmer S, Vecchio M, Craig JC, Tonelli M, Johnson DW, Nicolucci A, et al. Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int. 2013;84(1):179\u201391.","journal-title":"Kidney Int"},{"key":"4162_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.genhosppsych.2020.12.003","volume":"69","author":"CW Huang","year":"2021","unstructured":"Huang CW, Wee PH, Low LL, Koong YLA, Htay H, Fan Q, et al. Prevalence and risk factors for elevated anxiety symptoms and anxiety disorders in chronic kidney disease: A systematic review and meta-analysis. Gen Hosp Psychiatry. 2021;69:27\u201340.","journal-title":"Gen Hosp Psychiatry"},{"issue":"4","key":"4162_CR15","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.xkme.2019.07.002","volume":"1","author":"NG Choi","year":"2019","unstructured":"Choi NG, Sullivan JE, DiNitto DM, Kunik ME. Health care utilization among adults with CKD and psychological distress. Kidney Med. 2019;1(4):162\u201370.","journal-title":"Kidney Med"},{"issue":"2","key":"4162_CR16","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3390\/kidneydial2020021","volume":"2","author":"T Harris","year":"2022","unstructured":"Harris T. Lifestyle interventions in improving health outcomes and enabling people to live well with kidney disease. Kidney Dial. 2022;2(2):204\u20138.","journal-title":"Kidney Dial"},{"issue":"3","key":"4162_CR17","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1053\/j.ajkd.2014.03.020","volume":"64","author":"S Heiwe","year":"2014","unstructured":"Heiwe S, Jacobson SH. Exercise training in adults with CKD: A systematic review and meta-analysis. Am J Kidney Dis. 2014;64(3):383\u201393.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"4162_CR18","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12882-019-1309-y","volume":"20","author":"S Peng","year":"2019","unstructured":"Peng S, He J, Huang J, Lun L, Zeng J, Zeng S, et al. Self-management interventions for chronic kidney disease: A systematic review and meta-analysis. BMC Nephrol. 2019;20(1):142.","journal-title":"BMC Nephrol"},{"issue":"2","key":"4162_CR19","first-page":"189","volume":"19","author":"T Van de Moreels","year":"2024","unstructured":"Van de Moreels T, Goethals J, Vanden Wyngaert K, De Baets S, Nagler E, et al. Self-management interventions for facilitating life participation for persons with kidney failure: A systematic review. Clin J Am Soc Nephrol. 2024;19(2):189.","journal-title":"Clin J Am Soc Nephrol"},{"key":"4162_CR20","doi-asserted-by":"crossref","unstructured":"Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z. JBI manual for evidence synthesis - JBI global wiki [Internet]. JBI manual for evidence synthesis. 2024. Available from: https:\/\/jbi-global-wiki.refined.site\/space\/MANUAL","DOI":"10.46658\/JBIMES-24-01"},{"issue":"7","key":"4162_CR21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467\u201373.","journal-title":"Ann Intern Med"},{"key":"4162_CR22","first-page":"22","volume-title":"Enabling occupation II: adancing an occupational therapy vision of health, Well-being & justice through occupation","author":"HJ Polatajko","year":"2007","unstructured":"Polatajko HJ, Townsend EA, Craik J. The Canadian model of occupational performance and engagement (CMOP-E). Enabling occupation II: adancing an occupational therapy vision of health, Well-being & justice through occupation. Ottawa, ON: CAOT Publications ACE; 2007:22\u201336."},{"issue":"2","key":"4162_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ekir.2018.11.013","volume":"4","author":"S Shirazian","year":"2019","unstructured":"Shirazian S. Depression in CKD: Understanding the mechanisms of disease. Kidney Int Rep. 2019;4(2):189\u201390.","journal-title":"Kidney Int Rep"},{"issue":"6","key":"4162_CR24","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1177\/0004867414528589","volume":"48","author":"A Bautovich","year":"2014","unstructured":"Bautovich A, Katz I, Smith M, Loo CK, Harvey SB. Depression and chronic kidney disease: A review for clinicians. Aust N Z J Psychiatry. 2014;48(6):530\u201341.","journal-title":"Aust N Z J Psychiatry"},{"issue":"4","key":"4162_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.xkme.2019.07.003","volume":"1","author":"D Nair","year":"2019","unstructured":"Nair D. Measuring and modifying psychological distress in CKD: New insights and next steps. Kidney Med. 2019;1(4):147\u20139.","journal-title":"Kidney Med"},{"issue":"1","key":"4162_CR26","doi-asserted-by":"publisher","first-page":"17627","DOI":"10.1038\/s41598-022-21873-2","volume":"12","author":"S Alshelleh","year":"2022","unstructured":"Alshelleh S, Alhouri A, Taifour A, Abu-Hussein B, Alwreikat F, Abdelghani M, et al. Prevelance of depression and anxiety with their effect on quality of life in chronic kidney disease patients. Sci Rep. 2022;12(1):17627.","journal-title":"Sci Rep"},{"key":"4162_CR27","volume-title":"SF-36 physical and mental health summary scales: A user\u2019s manual","author":"JE Ware","year":"1994","unstructured":"Ware JE, Kosinski M, Keller SD. SF-36 physical and mental health summary scales: A user\u2019s manual. Boston, MA: Health Assessment Lab, New England Medical Center; 1994."},{"issue":"1","key":"4162_CR28","doi-asserted-by":"publisher","first-page":"18401","DOI":"10.1038\/s41598-023-44578-6","volume":"13","author":"X Kassianides","year":"2023","unstructured":"Kassianides X, Bhandari S. Patient reported outcome measures and cardiovascular outcomes following high dose modern intravenous iron in non-dialysis dependent chronic kidney disease: secondary analysis of ExplorIRON-CKD. Sci Rep. 2023;13(1):18401.","journal-title":"Sci Rep"},{"key":"4162_CR29","doi-asserted-by":"publisher","first-page":"e00061521","DOI":"10.1590\/0102-311x00061521","volume":"38","author":"M Bohlke","year":"2022","unstructured":"Bohlke M, Barcellos FC, Santos IS, Mielke GI, Vargas M, de Hallal M. Effects of a 16-week physical training on clinical outcomes in patients with hypertension and chronic kidney disease: NEPHROS post-trial follow-up. Cad Sa\u00fade P\u00fablica. 2022;38:e00061521.","journal-title":"Cad Sa\u00fade P\u00fablica"},{"issue":"18","key":"4162_CR30","doi-asserted-by":"publisher","first-page":"3804","DOI":"10.3390\/nu14183804","volume":"14","author":"A Saxena","year":"2022","unstructured":"Saxena A, Srinivasa S, Veerappan I, Jacob C, Mahaldar A, Gupta A, et al. Enzobiotics\u2014A novel therapy for the elimination of uremic toxins in patients with CKD (EETOX Study): A Multicenter Double-Blind Randomized Controlled Trial. Nutrients. 2022;14(18):3804.","journal-title":"Nutrients"},{"issue":"1","key":"4162_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.37526\/1526-744X.2022.49.1.19","volume":"49","author":"CJ Lightfoot","year":"2022","unstructured":"Lightfoot CJ, Vadaszky N, Watson EL, Robertson N, Smith AC. Perceptions and experiences of a progressive resistance exercise program in people with chronic kidney disease. Nephrol Nurshing J. 2022;49(1):19\u201327.","journal-title":"Nephrol Nurshing J"},{"issue":"1","key":"4162_CR32","first-page":"109","volume":"84","author":"XT Chen","year":"2022","unstructured":"Chen XT, Ou Q, He J, Yan ZH. Analysis of the efficacy of Alprostadil in combination with reduced glutathione on the chronic renal failure. Indian J Pharm Sci. 2022;84(1):109\u201312.","journal-title":"Indian J Pharm Sci"},{"key":"4162_CR33","doi-asserted-by":"crossref","unstructured":"Lightfoot CJ, Greenwood SA, Bramham K, Smith AC. Experiences of intravenous Iron therapy in non-anaemic functional Iron deficient individuals with non-dialysis kidney disease: A qualitative study. J Am Soc Nephrol. 2022.","DOI":"10.1681\/ASN.20223311S1905b"},{"issue":"1","key":"4162_CR34","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1002\/jcsm.12874","volume":"13","author":"Rhui Cha","year":"2022","unstructured":"Cha Rhui, Kang SH, Han MY, An WS, Kim SH, Kim JC. Effects of AST-120 on muscle health and quality of life in chronic kidney disease patients: results of RECOVERY study. J Cachexia Sarcopenia Muscle. 2022;13(1):397\u2013408.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"6","key":"4162_CR35","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1002\/jcsm.12775","volume":"12","author":"K Uchiyama","year":"2021","unstructured":"Uchiyama K, Adachi K, Muraoka K, Nakayama T, Oshida T, Yasuda M, et al. Home-based aerobic exercise and resistance training for severe chronic kidney disease: a randomized controlled trial. J Cachexia Sarcopenia Muscle. 2021;12(6):1789\u2013802.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"10S","key":"4162_CR36","doi-asserted-by":"publisher","first-page":"B5","DOI":"10.1681\/ASN.20203110S1B5b","volume":"31","author":"A Saxena","year":"2020","unstructured":"Saxena A, Jacob CK, Sreenivasa S, Veerappan I, Mahaldar AR, Gupta A, et al. A prospective, Double-Blind, randomized, Placebo-Controlled interventional study to evaluate the safety and efficacy of enzobiotics in Pre-Dialysis CKD patients: PO2628. J Am Soc Nephrol. 2020;31(10S):B5.","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"4162_CR37","doi-asserted-by":"publisher","first-page":"e19452","DOI":"10.2196\/19452","volume":"22","author":"WY Li","year":"2020","unstructured":"Li WY, Chiu FC, Zeng JK, Li YW, Huang SH, Yeh HC, et al. Mobile health app with social media to support Self-Management for patients with chronic kidney disease: prospective randomized controlled study. J Med Internet Res. 2020;22(12):e19452.","journal-title":"J Med Internet Res"},{"issue":"10196","key":"4162_CR38","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S0140-6736(19)31388-1","volume":"394","author":"DE Wesson","year":"2019","unstructured":"Wesson DE, Mathur V, Tangri N, Stasiv Y, Parsell D, Li E, et al. Long-term safety and efficacy of veverimer in patients with metabolic acidosis in chronic kidney disease: a multicentre, randomised, blinded, placebo-controlled, 40-week extension. Lancet. 2019;394(10196):396\u2013406.","journal-title":"Lancet"},{"issue":"1","key":"4162_CR39","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/ckj\/sfy071","volume":"12","author":"TJ Wilkinson","year":"2019","unstructured":"Wilkinson TJ, Watson EL, Gould DW, Xenophontos S, Clarke AL, Vogt BP, et al. Twelve weeks of supervised exercise improves self-reported symptom burden and fatigue in chronic kidney disease: a secondary analysis of the \u2018extra CKD\u2019 trial. Clin Kidney J. 2019;12(1):113\u201321.","journal-title":"Clin Kidney J"},{"issue":"1","key":"4162_CR40","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12882-018-1075-2","volume":"19","author":"K Havas","year":"2018","unstructured":"Havas K, Douglas C, Bonner A. Meeting patients where they are: improving outcomes in early chronic kidney disease with tailored self-management support (the CKD-SMS study). BMC Nephrol. 2018;19(1):279.","journal-title":"BMC Nephrol"},{"issue":"1","key":"4162_CR41","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s10157-017-1429-2","volume":"22","author":"DT Aoike","year":"2018","unstructured":"Aoike DT, Baria F, Kamimura MA, Ammirati A, Cuppari L. Home-based versus center-based aerobic exercise on cardiopulmonary performance, physical function, quality of life and quality of sleep of overweight patients with chronic kidney disease. Clin Exp Nephrol. 2018;22(1):87\u201398.","journal-title":"Clin Exp Nephrol"},{"key":"4162_CR42","doi-asserted-by":"crossref","unstructured":"Chen JW, Xie SQ. Agomelatine versus paroxetine in treating depressive and anxiety symptoms in patients with chronic kidney disease. Neuropsychiatr Dis Treat. 2018;14:547\u201352.","DOI":"10.2147\/NDT.S159636"},{"issue":"3","key":"4162_CR43","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.clnu.2016.05.012","volume":"36","author":"DR Mager","year":"2017","unstructured":"Mager DR, Jackson ST, Hoffmann MR, Jindal K, Senior PA. Vitamin D3 supplementation, bone health and quality of life in adults with diabetes and chronic kidney disease: results of an open label randomized clinical trial. Clin Nutr. 2017;36(3):686\u201396.","journal-title":"Clin Nutr"},{"issue":"12","key":"4162_CR44","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.2215\/CJN.11791113","volume":"9","author":"AP Rossi","year":"2014","unstructured":"Rossi AP, Burris DD, Lucas FL, Crocker GA, Wasserman JC. Effects of a renal rehabilitation exercise program in patients with CKD: A randomized, controlled trial. Clin J Am Soc Nephrol. 2014;9(12):2052.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"4162_CR45","first-page":"285","volume":"39","author":"A Nyg\u00e5rdh","year":"2012","unstructured":"Nyg\u00e5rdh A, Malm D, Wikby K, Ahlstrom G. Empowerment intervention in outpatient care of persons with chronic kidney disease pre-dialysis. Nephrol Nurs J. 2012;39(4):285\u201393.","journal-title":"Nephrol Nurs J"},{"issue":"4","key":"4162_CR46","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s11255-010-9823-7","volume":"43","author":"S Mustata","year":"2011","unstructured":"Mustata S, Groeneveld S, Davidson W, Ford G, Kiland K, Manns B. Effects of exercise training on physical impairment, arterial stiffness and health-related quality of life in patients with chronic kidney disease: a pilot study. Int Urol Nephrol. 2011;43(4):1133\u201341.","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"4162_CR47","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.sapharm.2008.06.004","volume":"5","author":"RA Hansen","year":"2009","unstructured":"Hansen RA, Chin H, Blalock S, Joy MS. Predialysis chronic kidney disease: evaluation of quality of life in clinic patients receiving comprehensive anemia care. Res Soc Adm Pharm. 2009;5(2):143\u201353.","journal-title":"Res Soc Adm Pharm"},{"issue":"12","key":"4162_CR48","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1185\/030079907X242502","volume":"23","author":"M Alexander","year":"2007","unstructured":"Alexander M, Kewalramani R, Agodoa I, Globe D. Association of anemia correction with health related quality of life in patients not on dialysis*. Curr Med Res Opin. 2007;23(12):2997\u20133008.","journal-title":"Curr Med Res Opin"},{"issue":"5","key":"4162_CR49","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1053\/j.ajkd.2006.02.170","volume":"47","author":"J Rossert","year":"2006","unstructured":"Rossert J, Levin A, Roger SD, H\u00f6rl WH, Fouqueray B, Gassmann-Mayer C, et al. Effect of early correction of Anemia on the progression of CKD. Am J Kidney Dis. 2006;47(5):738\u201350.","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"4162_CR50","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/0272-6386(95)90122-1","volume":"25","author":"DA Revicki","year":"1995","unstructured":"Revicki DA, Brown RE, Feeny DH, Henry D, Teehan BP, Rudnick MR, et al. Health-related quality of life associated with Recombinant human erythropoietin therapy for predialysis chronic renal disease patients. Am J Kidney Dis. 1995;25(4):548\u201354.","journal-title":"Am J Kidney Dis"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04162-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04162-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04162-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T13:04:26Z","timestamp":1747919066000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04162-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4162"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04162-8","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]},"assertion":[{"value":"23 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Co-first authors are student Occupational Therapists from the University of Toronto. The senior author is a registered Occupational Therapist and Assistant Professor from the Department of Occupational Science and Occupational Therapy at the University of Toronto. She holds a Canada Research Chair (Tier 2) in Life Participation and Kidney Disease.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author information"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"251"}}